Abstract
Reversible histone acetylation, governed dynamically by histone acetyltransferases (HATs) and histone deacetylases (HDACs), plays a pivotal role in regulation of gene expression through remodeling chromatin structure. Manipulation of the equilibrium between acetylation and deacetylation of histones by specific HDAC inhibitors is thus a useful tool to study functional role(s) for histone hyper-/hypoacetylation in controlling gene transcription and many other cellular activities. By using the trans-activating effect of trichostatin A (TSA), a widely used HDAC inhibitor, on the telomerase reverse transcriptase (hTERT) gene as an example, we summarize various aspects of HDAC inhibitors and provide a general strategy for their in vitro application in studies of gene regulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bannister, A. J., and Miska, E. A. (2000) Regulation of gene expression by transcription factor acetylation. Cell Mol Life Sci. 57, 1184–1192.
Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599–606.
Shankaranarayanan, P., Chaitidis, P., Kuhn, H., and Nigam, S. (2001) Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem. 276, 42,753–42,760.
Yoshida, M., Horinouchi, S., and Beppu, T. (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423–430.
Nimmanapalli, R., Fuino, L., Stobaugh, C., Richon, V. M., and Bhalla, K. (2003) Co-treatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances Gleevec-induced apoptosis of Bcr-Abl positive human acute leukemia cells. DOI 10.1182 Blood 101, 3236–3239.
Colletti, S. L., Myers, R. W., Darkin-Rattray, S. J., et al. (2001) Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Bioorg. Med. Chem. Lett. 11, 107–117.
Lee, B. I., Park, S. H., Kim, J. W., et al. (2001) MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells. Cancer Res. 61, 931–934.
Redner, R. L., Wang, J., and Liu, J. M. (1999) Chromatin remodeling and leukemia: new therapeutic paradigms. Blood 94, 417–428.
Kamitani, H., Geller, M., and Eling, T. (1998) Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J. Biol. Chem. 273, 21,569–21,577.
Bernhard, D., Ausserlechner, M. J., Tonko, M., Loffler, M., Hartmann, B. L., Csordas, A., and Kofler, R. (1999) Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J. 13, 1991–2001.
Taplick, J., Kurtev, V., Lagger, G., and Seiser, C. (1998) Histone H4 acetylation during interleukin-2 stimulation of mouse T cells. FEBS Lett. 436, 349–352.
Salminen, A., Tapiola, T., Korhonen, P., and Suuronen, T. (1998) Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res. Mol. Brain Res. 61, 203–206.
Han, J. W., Ahn, S. H., Park, S. H., et al. (2000) Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 60, 6068–6074.
Saito, A., Yamashita, T., Mariko, Y., et al. (1999) A synthetic inhibitor of histone deacetylase, MS-27–275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96, 4592–4597.
Marks, P. A., Richon, V. M., and Rifkind, R. A. (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92, 1210–1216.
Zhou, Q., Melkoumian, Z. K., Lucktong, A., Moniwa, M., Davie, J. R., and Strobl, J. S. (2000) Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1. J. Biol. Chem. 275, 35,256–35,263.
Hou, M., Wang, X., Popov, N., et al. (2002) The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274, 25–34.
Cong, Y. S. and Bacchetti, S. (2000) Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J. Biol. Chem. 275, 35,665–35,668.
Taniura, S., Kamitani, H., Watanabe, T., and Eling, T. E. (2002) Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277, 16,823–16,830.
Kamitani, H., Taniura, S., Ikawa, H., Watanabe, T., Kelavkar, U. P., and Eling, T. E. (2001) Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis 22, 187–191.
Takakura, M., Kyo, S., Sowa, Y., et al. (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res. 29, 3006–3011.
Sowa, Y., Orita, T., Minamikawa-Hiranabe, S., Mizuno, T., Nomura, H., and Sakai, T. (1999) Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59, 4266–4270.
Schwab, J. and Illges, H. (2001) Regulation of CD21 expression by DNA methylation and histone deacetylation. Int. Immunol. 13, 705–710.
Eickhoff, B., Germeroth, L., Stahl, C, et al. (2000) Trichostatin A-mediated regulation of gene expression and protein kinase activities: reprogramming tumor cells for ribotoxic stress-induced apoptosis. Biol. Chem. 381, 1127–1132.
Nakayama, T., Watanabe, M., Yamanaka, M., et al. (2001) The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers. Lab Invest. 81, 1049–1057.
Rombouts, K., Niki, T., Greenwel, P., et al. (2002) Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp. Cell Res. 278, 184–197.
Qiu, P. and Li, L. (2002) Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ. Res. 90, 858–865.
Gregory, R. I., O’Neill, L. P., Randall, T. E., et al. (2002) Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. J. Biol. Chem. 277, 11,728–11,734.
Xiao, H., Hasegawa, T., and Isobe, K. (1999) Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell Biochem. 73, 291–302.
Wang, X. Q., Alfaro, M. L., Evans, G. F., and Zuckerman, S. H. (2002) Histone deacetylase inhibition results in decreased macrophage CD9 expression. Biochem. Biophys. Res. Commun. 294, 660–666.
Xu, D., Popov, N., Hou, M., et al. (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. USA 98, 3826–3831.
Van Lint, C., Emiliani, S., and Verdin, E. (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene. Expr. 5, 245–253.
Gray, S. G. and Ekstrom, T. J. (1998) Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. Biochem. Biophys. Res. Commun. 245, 423–427.
Thiagalingam, S., Cheng, K. H., Lee, H. J., Mineva, N., Thiagalingam, A., and Ponte, J. F. (2003) Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. NY Acad. Sci. 983, 84–100.
Suenaga, M., Soda, H., Oka, M., et al. (2002) Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int. J. Cancer 97, 621–625.
Ito, K., Barnes, P. J., and Adcock, I. M. (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20, 6891–6903.
Zhang, W., Bone, J. R., Edmondson, D. G., Turner, B. M., and Roth, S. Y. (1998) Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J. 17, 3155–3167.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Liu, C., Xu, D. (2004). Inhibition of Histone Deacetylases. In: Tollefsbol, T.O. (eds) Epigenetics Protocols. Methods in Molecular Biology™, vol 287. Humana Press. https://doi.org/10.1385/1-59259-828-5:087
Download citation
DOI: https://doi.org/10.1385/1-59259-828-5:087
Publisher Name: Humana Press
Print ISBN: 978-1-58829-336-7
Online ISBN: 978-1-59259-828-1
eBook Packages: Springer Protocols